US regulators gave the green light to Autolus Therapeutics’ cell therapy for adult B cell precursor acute lymphoblastic leukemia, or B-ALL, that has returned or …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Mustang Bio has both amended and closed the agreement with CDMO uBriGene, to sell Mustang’s manufacturing facility. The new agreement will see uBriGene acquiring all
STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new
A qualitative study on the healthcare experiences of transgender adults identified needed interventions on both a provider and hospital level for providing competent, gender-affirming care.